Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

89,481 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Standardizing Definitions of Hematopoietic Recovery, Graft Rejection, Graft Failure, Poor Graft Function, and Donor Chimerism in Allogeneic Hematopoietic Cell Transplantation: A Report on Behalf of the American Society for Transplantation and Cellular Therapy.
Kharfan-Dabaja MA, Kumar A, Ayala E, Aljurf M, Nishihori T, Marsh R, Burroughs LM, Majhail N, Al-Homsi AS, Al-Kadhimi ZS, Bar M, Bertaina A, Boelens JJ, Champlin R, Chaudhury S, DeFilipp Z, Dholaria B, El-Jawahri A, Fanning S, Fraint E, Gergis U, Giralt S, Hamilton BK, Hashmi SK, Horn B, Inamoto Y, Jacobsohn DA, Jain T, Johnston L, Kanate AS, Kansagra A, Kassim A, Kean LS, Kitko CL, Knight-Perry J, Kurtzberg J, Liu H, MacMillan ML, Mahmoudjafari Z, Mielcarek M, Mohty M, Nagler A, Nemecek E, Olson TS, Oran B, Perales MA, Prockop SE, Pulsipher MA, Pusic I, Riches ML, Rodriguez C, Romee R, Rondon G, Saad A, Shah N, Shaw PJ, Shenoy S, Sierra J, Talano J, Verneris MR, Veys P, Wagner JE, Savani BN, Hamadani M, Carpenter PA. Kharfan-Dabaja MA, et al. Among authors: liu h. Transplant Cell Ther. 2021 Aug;27(8):642-649. doi: 10.1016/j.jtct.2021.04.007. Transplant Cell Ther. 2021. PMID: 34304802 Free article.
A novel clofarabine bridge strategy facilitates allogeneic transplantation in patients with relapsed/refractory leukemia and high-risk myelodysplastic syndromes.
Locke F, Agarwal R, Kunnavakkam R, van Besien K, Larson RA, Odenike O, Godley LA, Liu H, Le Beau MM, Gurbuxani S, Thirman MJ, Sipkins D, White C, Artz A, Stock W. Locke F, et al. Among authors: liu h. Bone Marrow Transplant. 2013 Nov;48(11):1437-43. doi: 10.1038/bmt.2013.79. Epub 2013 Jun 17. Bone Marrow Transplant. 2013. PMID: 23771005 Free PMC article. Clinical Trial.
Long-term survival after high-dose chemotherapy with autologous hematopoietic cell transplantation in metastatic breast cancer.
Hamilton BK, Rybicki L, Abounader D, Andresen S, Kalaycio M, Sobecks R, Pohlman B, Hanna R, Dean R, Liu H, Hill B, Bolwell B, Copelan E. Hamilton BK, et al. Among authors: liu h. Hematol Oncol Stem Cell Ther. 2015 Sep;8(3):115-24. doi: 10.1016/j.hemonc.2015.06.005. Epub 2015 Jul 7. Hematol Oncol Stem Cell Ther. 2015. PMID: 26183670 Free article.
Does day 11 omission of methotrexate due to toxicity influence the outcome in myeloablative hematopoietic cell transplant? Results from a single-center retrospective cohort study.
Hamilton BK, Rybicki L, Haddad H, Abounader D, Yurch M, Majhail NS, Hanna R, Sobecks R, Dean R, Liu H, Hill B, Copelan E, Bolwell B, Kalaycio M. Hamilton BK, et al. Among authors: liu h. Blood Cancer J. 2015 Aug 28;5(8):e344. doi: 10.1038/bcj.2015.70. Blood Cancer J. 2015. PMID: 26314986 Free PMC article. No abstract available.
Daily Weight-Based Busulfan with Cyclophosphamide and Etoposide Produces Comparable Outcomes to Four-Times-Daily Busulfan Dosing for Lymphoma Patients Undergoing Autologous Stem Cell Transplantation.
Hill BT, Rybicki L, Carlstrom KD, Jagadeesh D, Gerds A, Hamilton B, Liu H, Dean R, Sobecks R, Pohlman B, Andresen S, Kalaycio M, Bolwell BJ, Majhail NS. Hill BT, et al. Among authors: liu h. Biol Blood Marrow Transplant. 2016 Sep;22(9):1588-1595. doi: 10.1016/j.bbmt.2016.06.011. Epub 2016 Jun 22. Biol Blood Marrow Transplant. 2016. PMID: 27343718 Free article.
GvHD-free, relapse-free survival after reduced-intensity allogeneic hematopoietic cell transplantation in older patients with myeloid malignancies.
Nazha A, Rybicki L, Abounader D, Bolwell B, Dean R, Gerds AT, Jagadeesh D, Hamilton BK, Hill BT, Kalaycio M, Liu H, Pohlman B, Sobecks R, Sekeres MA, Majhail NS. Nazha A, et al. Among authors: liu h. Bone Marrow Transplant. 2016 Dec;51(12):1642-1643. doi: 10.1038/bmt.2016.254. Epub 2016 Oct 10. Bone Marrow Transplant. 2016. PMID: 27721371 No abstract available.
Comparative Effectiveness of Busulfan and Fludarabine versus Fludarabine and 400 cGy Total Body Irradiation Conditioning Regimens for Acute Myeloid Leukemia/Myelodysplastic Syndrome.
Mustafa Ali M, Abounader DM, Rybicki LA, Yurch MA, Starn J, Ferraro C, Winslow V, Hamilton BK, Gerds AT, Liu H, Dean R, Hill BT, Pohlman B, Andresen S, Hanna R, Kalaycio M, Bolwell BJ, Majhail NS, Sobecks RM. Mustafa Ali M, et al. Among authors: liu h. Biol Blood Marrow Transplant. 2017 May;23(5):776-781. doi: 10.1016/j.bbmt.2017.01.077. Epub 2017 Jan 17. Biol Blood Marrow Transplant. 2017. PMID: 28108271 Free article.
Prognostic value of pre-transplant PET/CT in patients with diffuse large B-cell lymphoma undergoing autologous stem cell transplantation.
Winter A, Rybicki L, Shah SN, Jagadeesh D, Gerds AT, Hamilton BK, Liu H, Dean R, Sobecks R, Pohlman B, Smith M, Kalaycio M, Bolwell BJ, Majhail NS, Hill BT. Winter A, et al. Among authors: liu h. Leuk Lymphoma. 2018 May;59(5):1195-1201. doi: 10.1080/10428194.2017.1369065. Epub 2017 Aug 30. Leuk Lymphoma. 2018. PMID: 28853617
Impact of cigarette smoking on survival after myeloablative allogeneic hematopoietic stem cell transplantation and contribution of invasive fungal infection.
Mehdi A, Rybicki L, Mossad S, Yurch M, Sekeres M, Gerds AT, Jagadeesh D, Hamilton B, Liu H, Dean R, Pohlman B, Sobecks R, Andresen S, Kalaycio M, Bolwell BJ, Majhail NS, Copelan E, Hill BT. Mehdi A, et al. Among authors: liu h. Bone Marrow Transplant. 2017 Dec;52(12):1665-1667. doi: 10.1038/bmt.2017.184. Epub 2017 Sep 4. Bone Marrow Transplant. 2017. PMID: 28869614 Clinical Trial. No abstract available.
Neutropenic fever during peripheral blood progenitor cell mobilization is associated with decreased CD34+ cell collection and increased apheresis collection days.
Khouri J, Rybicki L, Majhail N, Kalaycio M, Copelan E, Pohlman B, Hill B, Dean R, Lazaryan A, Hamilton B, Andresen S, Sobecks R, Bolwell B, Liu H. Khouri J, et al. Among authors: liu h. J Clin Apher. 2018 Jun;33(3):303-309. doi: 10.1002/jca.21605. Epub 2017 Nov 14. J Clin Apher. 2018. PMID: 29134688
89,481 results
You have reached the last available page of results. Please see the User Guide for more information.